MEGAKARYOCYTE DIFFERENTIATION

巨核细胞分化

基本信息

  • 批准号:
    2228408
  • 负责人:
  • 金额:
    $ 20.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1994
  • 资助国家:
    美国
  • 起止时间:
    1994-02-01 至 1998-01-31
  • 项目状态:
    已结题

项目摘要

The long term objective of this research program is to significantly enhance our understanding of megakaryopoeisis at the molecular level. Three specific aims are proposed. The first is to document the role of the c-ski proto-oncogene in megakaryopoeisis. Preliminary studies in several human hematopoietic tumor cell lines showed that expression of the c-ski proto-oncogene is specifically induced during in vitro megakaryocyte differentiation but not during erythroid or myeloid differentiation. The importance of ski expression in mediating megakaryocyte differentiation will be tested by inhibiting its activity in various hematopoietic cell lines through use of antisense oligonucleotides, antisense RNA, ribozymes, and a dominant-negative mutant of ski. Additionally, overexpression of ski in the same cell lines will be examined to determine if ski expression, by itself, is sufficient to induce the initial stages of megakaryocytic differentiation. The ski protein appears to be a transcription factor that binds specific responsive elements in DNA, and these sequences have been located in the promoter regions of four platelet/megakaryocytic specific genes, as well as in the upstream region of the gene encoding the erythroid/megakaryocytic transcription factor GATAI. Therefore, the role of ski-responsive elements in these cell lines will also be examined, through the use of appropriate reporter constructs. The second specific aim is to identify, in a model cell line, CHRF-288-11, mRNAs whose expression changes during megakaryocyte differentiation. These will be identified using two recently developed PCR-based cDNA cloning techniques; differential display, and a gene expression screen. Once obtained, these cDNAs will be used for the experiments described in the third specific aim, which is to determine if their expression is necessary and/or sufficient for differentiation to occur. These experiments will employ overexpression and inhibition of expression techniques similar to the ones outlined in the first specific aim, in which the role of the c-ski protooncogene was assessed. In this manner genes important in regulating megakaryopoeisis will be identified allowing their mechanism(s) of action to be determined. With this information in hand, it may become feasible to design agents to artificially manipulate the expression of these genes, which has important implications both for treating diseases in which platelet production is impaired, and for engraftment of megakaryocytes after bone marrow transplantation.
这项研究计划的长期目标是显著地 在分子水平上提高我们对巨核细胞生成的理解。 提出了三个具体目标。第一个是记录 巨核细胞生成中的c-ski原癌基因。中国的初步研究 几种人类造血肿瘤细胞系显示其表达 C-ski原癌基因在体外被特异性地诱导。 巨核细胞分化,但红系或髓系不分化 差异化。SKI表达在调解中的重要性 将通过抑制巨核细胞的活性来测试其分化 通过使用反义基因在不同的造血细胞系中 寡核苷酸、反义RNA、核酶和显性负性 滑雪的变种人。此外,SKI在同一细胞中过表达 将检查各行以确定ski表达式本身是否 足以诱导巨核细胞的初始阶段 差异化。SKI蛋白似乎是一种转录因子 它结合了DNA中特定的反应元件,这些序列 已经定位在四个启动子区域 血小板/巨核细胞特异性基因及其上游 编码红系/巨核细胞转录的基因区域 加泰因素。因此,滑雪反应元件在这些 细胞系也将通过使用适当的 记者构建。第二个具体目标是在模型中识别 CHRF-288-11细胞株,其表达在 巨核细胞分化。这些将使用两个 最近发展起来的基于聚合酶链式反应的cdna克隆技术;差异 显示,以及基因表达屏幕。一旦获得,这些DNA将 用于第三个具体目标中描述的实验,即 就是确定它们的表达对于 分化才会发生。这些实验将使用过度表达 和抑制表达技术,类似于概述的那些 在第一个特定目标中,c-ski原癌基因的作用 进行了评估。在这种情况下,重要的基因调控 巨核细胞生成将被确定为允许他们的机制(S) 行动待定。有了这些信息,它可能会成为 可行的设计代理人来人工操纵的表达 这些基因,这对治疗 血小板生成受损的疾病,并用于植入 骨髓移植后巨核细胞的数量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL A LIEBERMAN其他文献

MICHAEL A LIEBERMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL A LIEBERMAN', 18)}}的其他基金

MEGAKARYOCYTE DIFFERENTIATION
巨核细胞分化
  • 批准号:
    2332521
  • 财政年份:
    1994
  • 资助金额:
    $ 20.74万
  • 项目类别:
MEGAKARYOCYTE DIFFERENTIATION
巨核细胞分化
  • 批准号:
    2228407
  • 财政年份:
    1994
  • 资助金额:
    $ 20.74万
  • 项目类别:
MEGAKARYOCYTE DIFFERENTIATION
巨核细胞分化
  • 批准号:
    2228409
  • 财政年份:
    1994
  • 资助金额:
    $ 20.74万
  • 项目类别:
REGULATION OF CELLULAR GROWTH AND DIFFERENTIATION
细胞生长和分化的调节
  • 批准号:
    2099839
  • 财政年份:
    1993
  • 资助金额:
    $ 20.74万
  • 项目类别:
REGULATION OF CELLULAR GROWTH AND DIFFERENTIATION
细胞生长和分化的调节
  • 批准号:
    2429774
  • 财政年份:
    1993
  • 资助金额:
    $ 20.74万
  • 项目类别:
REGULATION OF CELLULAR GROWTH AND DIFFERENTIATION
细胞生长和分化的调节
  • 批准号:
    2099840
  • 财政年份:
    1993
  • 资助金额:
    $ 20.74万
  • 项目类别:
REGULATION OF CELLULAR GROWTH AND DIFFERENTIATION
细胞生长和分化的调节
  • 批准号:
    2099838
  • 财政年份:
    1993
  • 资助金额:
    $ 20.74万
  • 项目类别:
REGULATION OF CELLULAR GROWTH AND DIFFERENTIATION
细胞生长和分化的调节
  • 批准号:
    2099841
  • 财政年份:
    1993
  • 资助金额:
    $ 20.74万
  • 项目类别:
GROWTH REGULATION BY A PLASMA MEMBRANE MITOGEN
质膜丝裂原的生长调节
  • 批准号:
    3283450
  • 财政年份:
    1984
  • 资助金额:
    $ 20.74万
  • 项目类别:
GROWTH REGULATION BY A PLASMA MEMBRANE MITOGEN
质膜丝裂原的生长调节
  • 批准号:
    3283449
  • 财政年份:
    1984
  • 资助金额:
    $ 20.74万
  • 项目类别:

相似海外基金

NOVEL RNASE PROTECTION ASSAY FOR CYTOKINE MRNAS
细胞因子 MRNAS 的新型 RNA 酶保护测定
  • 批准号:
    6317727
  • 财政年份:
    2000
  • 资助金额:
    $ 20.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了